Description

CJC-1295 DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to enhance growth hormone (GH) secretion. By binding to albumin in the bloodstream, the DAC (Drug Affinity Complex) significantly extends the peptide’s half-life, allowing for sustained GH stimulation over days.

CJC-1295 without DAC is a shorter-acting synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the release of endogenous growth hormone (GH). Without the Drug Affinity Complex (DAC), it has a shorter half-life compared to its DAC counterpart, leading to more transient increases in growth hormone and IGF-1 levels.

The combination of CJC-1295 No DAC and Ipamorelin is used to synergistically enhance endogenous GH release by targeting different pathways in the pituitary gland. CJC-1295, a GHRH analog, stimulates prolonged GH release, while Ipamorelin, a selective GH secretagogue, mimics ghrelin to trigger immediate GH pulses in test subjects and studies.

*you will need a RECONSTITUTION KIT